Targeted therapy represents a specialized and growing segment of the US Melanoma Market, focusing on drugs that interfere with specific molecular pathways essential for cancer growth. These treatments are highly effective for patients whose tumors harbor specific genetic mutations, such as the BRAF mutation, which is present in approximately half of all melanoma cases.
The success of targeted...
Deutsch 
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Tiếng Việt